[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Doctor_Salomon Avatar @Doctor_Salomon Dr. Salomon

Dr. Salomon posts on X about $vktx, $lly, weight loss, $nvo the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% currencies XXXX%

Social topic influence $vktx #11, $lly #17, weight loss #660, $nvo #38, $vik 18.18%, if you 9.09%, future 9.09%, market cap XXXX%

Top accounts mentioned or mentioned by @bioinvestor24 @cardioraj @wa154lco @jcannush @pacha_8x @meadowcapital @elaineywchen @pkfund @breakoutchrts @jp_sed @pk_fund @trentkelp @eastglaciermt @enhancementwiki @bruce_huds77512 @maugusterfer @upandtotherght @scottz06 @wallstsai @joeyang043

Top assets mentioned Viking Therapeutics, Inc (VKTX) Eli Lilly and Company (LLY) Novo-Nordisk (NVO) Viking Holdings Ltd (VIK)

Top Social Posts

Top posts by engagements in the last XX hours

"Powerful testimonies of $VKTX XX% weight loss in XX weeks with no side effects. As a doctor I predict the obesity epidemic will trend down worldwide. Viking and $LLY tirzepatide will be the leaders (both have GIP and GLP-1 effect). Thanks to $NVO for opening the space with semaglutide (only GLP-1 effect). Please let me know if you agree that tirzepatide is better than semaglutide"
X Link 2025-12-01T19:38Z 105.3K followers, 22.8K engagements

"@bioinvestor24 Check this: Viking Therapeutics $VKTX has Overweight Rating from Cantor Fitzgerald @bioinvestor24"
X Link 2025-12-09T01:31Z 105.3K followers, XXX engagements

"$VKTX had less side effects than retatrutide $VKTX had more weight loss than tirzepatide In 2024 $NVO had the best obesity drug In 2025 $LLY had the best obesity drug Today VKTX has the best obesity drug"
X Link 2025-12-11T12:15Z 105.3K followers, 10.7K engagements

"@cardioraj Many investors were waiting for the retatrutide data. Today they will start buying $VKTX without the retatrutide risk because retatrutide has more side effects than VKTX. I was waiting to buy much more"
X Link 2025-12-11T14:14Z 105.3K followers, XXX engagements

"Do we really need retatrutide $LLY - Tirzepatide is already excellent - Retatrutide caused dysesthesias (21%) $VKTX is similar to Tirzepatide. LLY and VKTX are the future"
X Link 2025-12-11T18:52Z 105.3K followers, 1088 engagements

"@PK_Fund It wasn't a smart move. I got scared because retatrutide had very high expectations but it failed. Now $VKTX has the best obesity drug. It's only $X billion market cap and chasing $LLY $X Trillion"
X Link 2025-12-12T12:17Z 105.3K followers, XXX engagements

"@bioinvestor24 Besides $VKTX Is any other obesity drug in phase X with data good enough to be a tirzepatide competitor (With better tolerability and higher weight loss than tirzepatide in phase 3) Thanks @bioinvestor24"
X Link 2025-12-02T15:57Z 105.3K followers, XXX engagements

"@breakoutchrts Wow. I didn't know phase X drugs could be awarded National Priority Voucher by the FDA. I hope $VKTX applied. They could be granted"
X Link 2025-12-03T15:13Z 105.3K followers, 1073 engagements

"@wa154lco Good point. You are very likely correct. $LLY will not let $VKTX get acquired by a competitor"
X Link 2025-12-11T18:58Z 105.3K followers, XXX engagements

"@JCanNuSH Good idea. Has anyone complain of dysesthesias on the r/Zepbound forum on Reddit A neurologic side effect worries me a lot. Thanks @JCanNuSH"
X Link 2025-12-12T17:15Z 105.3K followers, XX engagements